The coagulopathy of acute promyelocytic leukemia (APL) is mainly related to procoagulant substances and fibrinolytic activators of APL blasts, but the fate of these leukemic cells is unknown. The aim of this study was to investigate the removal of APL blasts by macrophages and endothelial cells in vitro and consequent procoagulant and fibrinolytic activity of APL cells. We found that human umbilical vein endothelial cells as well as THP-1 and monocyte-derived macrophages bound, engulfed and subsequently degraded immortalized APL cell line NB4 and primary APL cells. Lactadherin promoted phagocytosis of APL cells in a time-dependent fashion. Furthermore, factor Xa and prothrombinase activity of PS-exposed target APL cells was time-dependently decreased after incubation with phagocytes (THP-1-derived macrophages or human umbilical vein endothelial cells). Thrombin production on target APL cells was reduced by 40-45% after two hours of coincubation with phagocytes, and 80% by a combination of lactadherin and phagocytes.
Introduction
Acute promyelocytic leukemia (APL) is characterized by the dual phenomenon of life-threatening thrombosis and bleeding 1, 2 as well as the accumulation of immature promyelocytes. 3 Although this disease represents a paradigm for successful target treatment with remarkable advances at both the clinical and laboratory levels, 4 ,5 the removal process of APL cells remains to be investigated.
Phosphatidylserine (PS) is a critical 'eat me' signal for phagocytes. 6, 7 Our and other prior reports have demonstrated that viable and apoptotic APL cells expose PS. 8, 9 It is conceivable that due to uncontrolled APL blast proliferation and chemotherapy, 9 professional macrophages (MΦ) may become overwhelmed by the excessive amounts of PS-exposed APL blasts. This may lead to the clearance of these cell corpses by amateur phagocytes, such as ubiquitously distributed endothelial cells (ECs). Hence, we speculate that both MΦ and ECs contribute to the removal of APL cells.
In addition, exposed PS on cells provides a catalytic surface for the assembly of tenase and prothrombinase complexes. 10 Our previous study indicated that PS exposure is a major mechanism through which APL blasts enhance procoagulant activity (PCA). 8 Furthermore, clinical hemorrhage in patients with APL is thought to be due to disseminated intravascular coagulation, abnormal fibrinolysis, or both. 11 However, the contribution of phagocytosis by scavengers to the PCA and fibrinolytic activity (FLA) of APL cells is still unclear. In view of this fact, we infer that changes in clearance of APL blasts may influence the established clinical patterns when coagulation abnormalities worsen or improve depending on the type of treatment.
Lactadherin, a milk fat globule membrane glycoprotein, 12 is secreted by MΦ and ECs. 13, 14 This protein contains a domain structure of EGF1-EGF2-C1-C2. 15 It anchors PS-externalized cells through its C-terminus to phagocyte α v β 3/5 integrins for engulfment via its RGD motif in the EGF2 domain. 16 Recently, lactadherin has been shown to promote elimination of platelet-derived microparticles by MΦ, 17 and to mediate phagocytosis of microparticles 18 and melanoma cells 19 by angiogenic ECs. Moreover, lactadherin binds to PS-containing membranes, competing for membrane sites recognized by factor V and factor VIII. 15, 20 We previously found that it reduces the PCA of APL cells. 8 Considering these properties, we have further investigated the cooperative effect of lactadherin and phagocytosis on the PCA and FLA of APL cells.
In the present study, we explored the phagocytosis of APL cells by MΦ and ECs in vitro and its relevance to the PCA and FLA of APL cells. In addition, we investigated the role of lactadherin in
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Patients, materials, and methods

Patients
Sixteen newly diagnosed APL patients admitted to the First and Second Affiliated Hospital of Harbin Medical University between May 2010 and October 2011 were studied after informed consent. This study was approved by Ethics Committee of Harbin Medical University and conducted in accordance with the Declaration of Helsinki. The diagnosis was based on clinical data, morphology, cytochemistry, immunology, cytogenetics and molecular biology. 8 Cytogenetic analysis indicated the t(15;17) translocation and PML/RARα fusion gene in all cases. The main characteristics of the patients at the moment of bone marrow aspiration were reported on Table 1 .
Reagents
Endothelial cell medium was purchased from ScienCell (San Diego, CA, USA 21 were cultured in endothelial cell medium containing 5 % FBS, 1% endothelial cell growth supplement and antibiotics.
Preparation of MΦ
As previously described, 22 peripheral blood mononuclear cells from healthy volunteers were isolated by Ficoll-Hypaque density gradient centrifugation. Positive isolation of primary monocytes from mononuclear cells was performed using a magnetic activated cell sorting starting kit with human CD14 + microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were cultured in 10% FBS-containing complete RPMI1640 medium and allowed to differentiate into MΦ for 5 days.
Alternatively, THP-1-derived MΦ were obtained by stimulating THP-1 monocytes with 20 ng/mL phorbol 12-myristate 13-acetate for 72 hours.
22
Coincubation assay
Viable APL cells from each patient with APL or NB4 cells at a density of 5×10 5 /mL were exposed to various concentrations of DNR (0.1, 0. Lactadherin-opsonized or annexin V-opsonized targets were obtained as follows: target APL cells were preincubated with 2 nM lactadherin or annexin V for 10 minutes at room temperature, followed by washing and removal of free proteins-containing supernatant solution. In some instances, these opsonized cells were co-incubated with MΦ or HUVECs monolayers. 
Flow cytometry
Confocal microscopy
To locate PS, NB4 or APL cells were incubated with the indicated concentrations of PI and fluorescein-labeled lactadherin or annexin V. 24 Cells were washed to remove unbound proteins and analyzed immediately. The samples were excited with 488 nm emission line of a krypton-argon laser, and narrow bandpass filters were utilized to restrict emission wavelength overlap. Images were captured using Zeiss LSM 510 Meta confocal microscope (Carl Zeiss Jena GmbH, Jena, Germany).
NB4 or APL cells on coverslips were fixed with 3.7% formaldehyde at room temperature for 10 minutes and then washed with PBS. Samples with or without permeabilization were exposed to goat anti
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Engulfment was detected by modified method as previously described. 21 Briefly , 
Electron microscopy
In scanning electron microscope assays, target APL cells were co-cultured with MΦ or ECs on coverslips.
Samples were fixed by immersion in 2.5% glutaraldehyde-phosphate fixative and stored at 4℃ until processed. Following several rinses in 0.1 M Na-cacodylate HCl buffer, co-cultivations were postfixed in 1% OsO 4 and dehydrated in a graded series of ethanol (30, 50, 70, 90 and 100%; twice in 5 minutes). After critical drying, a layer of platinum, approximately 10 nm thick, was sprayed on the samples. All images were viewed with a S-3400N Scanning Electron Microscope (Hitachi Ltd., Tokyo, Japan) using an ultra-high-resolution mode.
In transmission electron microscope experiments, the mixed cells were collected and double fixed in 2.5% glutaraldehyde and 1% OsO 4 . After dehydration and embedding, ultrathin sections were prepared with Reichert-Jung Ultracut Ultramicrotome (Leica, Vienna, Austria). Images were observed under a H7650 transmission electron microscope (Hitachi Ltd., Tokyo, Japan).
Coagulation time
Target APL cells with or without opsonization by lactadherin or annexin V were co-cultured with MΦ or ECs in 12-well culture plates as described in the "Coincubation assay", the mixed cells were harvested and resuspended in 100 µL Tyrode's buffer. Moreover, 1×10 6 target APL cells with or without opsonization were suspended in 100 µL Tyrode's buffer. PCA was determined by a modified prothrombin time test. 27 Briefly, 100 µL of the cell suspension was mixed 1:1 with citrated platelet-poor plasma temperature. Thrombin production was evaluated immediately at 405 nm in the kinetic microplate reader using S-2238 (0.8 mM) after the addition of EDTA.
Plasmin production tests
A previously described method with minor modification was used to measure plasmin formation. 25, 28 In brief, cells were preincubated with 10 nM t-PA for 10 minutes and washed twice with PBS. After addition of 200 nM glu-plasminogen for 10 minutes at room temperature in 96-well culture plates, 200 μM plasmin substrate S2251 was added to each well. Generation of plasmin was assayed at 405 nm using a SpectraMax M5 Microplate Reader, and was then calculated according to a calibration curve for standard plasmin.
Statistical analysis
All values were presented as mean ± standard deviation for at least three replicates. Statistical analysis was analyzed with Student t-test. P＜.05 was considered statistically significant.
Results
PS exposure on NB4 and APL cells
DNR was used to induce PS exposure on NB4 and APL cells. 9 The extent of PS exposure was measured through either annexin V or lactadherin binding using flow cytometry ( Figure 1A ). 
Clearance of NB4 and APL cells by MΦ
Two sources of primary macrophages (MΦ) were used as in vitro models of phagocytic clearance.
Monocytes isolated from human blood were allowed to differentiate into MΦ. Alternatively, THP-1-derived MΦ, which have similar properties to monocyte-derived MΦ, were obtained by stimulation with phorbol 12-myristate 13-acetate. 29 The target NB4 or APL cells showed morphological features of apoptosis, including loss of most microvilli, karyopyknosis and chromatin aggregation ( Untreated NB4 cells and viable APL blasts had numerous slender microvilli and did not display apoptotic features. However, some of the cells were still taken up by MΦ (data not shown).
Elimination of NB4 and APL cells by ECs
Since ECs have been reported to behave as amateur phagocytes for dying cells, 19, 21 we utilized the α v -expressing model HUVECs 19 to study the fate of NB4 and APL cells after coincubation with ECs. Within 1 hour of incubation, target NB4 and APL cells bound to the ECs surface ( Figure 3A -B). Targets with apoptotic bodies were incorporated into ECs after 1.5 hours ( Figure 3C ). Separated apoptotic bodies of a target APL cell were phagocytosed by the EC after 2 hours ( Figure 3D ). At 3 hours, target APL cells were digested within the ECs ( Figure 3E ). By this time point, nearly all phagocytosed intracellular materials had disappeared, suggesting degradation was virtually complete ( Figure 3F ). These results demonstrated that phagocytosis of PS-exposed APL cells by ECs was indeed occurring. In addition, ECs engulfed some viable APL cells (data not shown).
For
Lactadherin promoted the phagocytosis of APL cells
Lactadherin acts as a bridge between PS-exposed cells and phagocytes. 16 In order to explore the contribution of lactadherin to the uptake of APL cells, the amount of phagocytosis was further measured by flow cytometry. Based on the microscopic observations as described above, the extent of phagocytosis before 2 hours was first evaluated. We found that compared with PS-exposed APL cells without lactadherin opsonization, target APL cells pretreated with lactadherin showed a greater enhanced phagocytosis by both kinds of phagocytes at all time points, in a time-dependent manner ( Figure 4A ). In the absence of lactadherin, the level of uptake was about 10% by either THP-1-derived MΦ or HUVECs at 2 hours ( Figure 4B ). 
Lactadherin and phagocytes cooperatively reduced PCA of APL cells
In the subsequent experiment, we investigated the possibilities of cooperative effect of lactadherin and 
Phagocytosis with or without lactadherin decreased FLA of APL cells
Major determinants of coagulation disorder in APL are related to not only PCA but also fibrinolytic properties of APL cells. 30 We explored the relationship between engulfment and fibrinolysis. A plasminogen activation test was used to measure the generation of cell-surface plasmin. In contrast, THP-1-derived MΦ or HUVECs showed little plasmin generation ( Figure 7A ). When we added target APL cells to either phagocytes, the plasmin production of the mixed cells was reduced in a time-dependent fashion. Plasmin production was inhibited about 30% after a 2-hour incubation with THP-1-derived MΦ or HUVECs. We further examined the effect of lactadherin-mediated phagocytosis on plasmin generation of APL targets ( Figure 7B ). At 2 hours, lactadherin and phagocytes cooperation reduced approximately 50% plasmin production of APL target blasts. Annexin V had little effect on plasmin production. Taken together, our data indicated that engulfment of target APL blasts attenuated plasmin generation and decreased more with lactadherin-opsionized phagocytosis.
Previous studies revealed that abnormally high levels of annexin II in promyelocytes promote plasmin generation, perhaps accounting for the relatively high incidence of hyperfibrinolysis-related bleeding in APL. 25 Subsequently, we assessed the annexin II expression of promyelocytes and phagocytes (THP-1 macrophages and HUVECs). Consistent with the prior observation using a fluorescein-tagged antibody, Figure 7E, left) . We also found annexin II expression both on the membrane and in the cytoplasm of THP-1 MΦ (Figure 7E, middle) . Though the amount of annexin II expression on HUVECs surface was low, cytoplasmic annexin II was accessible ( Figure 7E , right).
Discussion
Our results showed that both cultured MΦ and ECs phagocytosed APL blasts and that lactadherin promoted this engulfment in a time-dependent manner. Phagocytosis inhibited both the PCA and FLA of APL cells.
Lactadherin and phagocytosis could cooperatively improve the coagulation disturbance in APL.
MΦ throughout the body clear apoptotic cells rapidly and efficiently. 7 PS works as a recognition cue for phagocytosis. 6, 7 Previous studies have also shown that activated MΦ destroy tumor cells. 31 We found that MΦ were able to recognize, engulf and ultimately dispose of PS-exposed NB4 and APL cells. That two human MΦ subsets from different origin (primary and cell line-derived MΦ) both ingested APL cells indicates that it is a general property of MΦ, not related to one particular cell type. Here, orchestrated elimination of apoptotic APL cells is important to avoid leakage of cell contents and to limit inflammatory or immunogenic responses. 7 Clinical trials of systemic MΦ activation for therapy of disseminated metastases progress successfully in some carcinomas. 32 Therefore, the phagocytic capacity of MΦ toward APL cells presents an attractive possibility for APL therapy.
In APL, due to uncontrolled leukemia proliferation and chemotherapy, 9 MΦ may be overwhelmed by large numbers of PS-exposed APL cells. The burden for phagocytes may be highest after cytotoxic chemotherapy when a large number of circulating APL cells enter apoptosis. It is therefore not surprising that non-professional ECs, the cells that line blood vessels in every organ system, 33 may contribute adjunctive phagocytic activity. 19, 21 In our study, HUVECs bound, engulfed and subsequently digested APL blasts. As we clarify that APL blasts can be engulfed by a cell type beyond the mononuclear phagocyte system, our results seems to provide a novel strategy to study uptake of leukemic cells in vitro. Nevertheless,
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Our current data indicated that phagocytosis by MΦ and ECs decreased PCA of PS-exposed APL cells with time. We previously reported that the major PCA of APL cells is PS-dependent, and the active tissue factor on APL blasts is most likely localized in the membrane areas where PS and tissue factor overlap. 8 Prior studies showed that excessive PCA of APL is associated with formation of factor Xa through a cysteine protease, named cancer procoagulant 35, 36 as well as by expression of tissue factor. 1,37 PCA of cancer procoagulant is not dependent upon exposed PS and appears to account for about 20% of factor Xa generation by NB4 cells as well as by leukemic blasts from patients with APL. 8 The degree of inhibition of both intrinsic and extrinsic factor Xa complexes by PS-blockade in this study is consistent with the expected residual contribution from cancer procoagulant. Thus, we speculate that internalization of APL blasts by phagocytes decreases PCA due to both tissue factor and cancer procoagulant. As a result, the progression of pathologic coagulation process may be prevented.
Annexin II, the tissue plasminogen activator (t-PA) and plasminogen binding receptor, is overexpressed on leukemic promyelocytes. 25 Annexin II plays an important role in plasmin generation resulting in increased fibrinolysis and offers a link to the hemorrhagic diathesis in APL. 25 In agreement with a recent study, 38 we found that DNR lowered the amount of annexin II on NB4 or APL cells. Consequently, this drug also reduced plasmin generation of APL cells. We speculated that due to reduced markers of fibrinolytic activation, phagocytosis by phagocytes for 2 hours statistically decreased FLA of APL targets.
Lactadherin exists in normal plasma 39 and on the outer surface of human MΦ 13 and ECs. 14, 40 This opsonin serves as a bridge between PS on apoptotic cells and integrins on phagocytes. 16 Lactadherin-deficient mice show defective clearance of apoptotic cells. 41 Addition of recombinant lactadherin can correct this defect. 42 In this study, the inhibition of phagocytosis in the presence of annexin V, a protein that has a PS-binding domain but no integrin binding domain, indicated a major role for PS in this process. Furthermore, we found that in a time-dependent manner, lactadherin promoted the phagocytosis of APL cells by both MΦ and ECs. While, 
domains of factors V and VIII. 43 This allows lactadherin, through binding to PS-containing membranes, to act as an anticoagulant. 20, 44 Our results indicated that compared with the anticoagulant effect of lactadherin or phagocytosis alone, lactadherin and phagocytes might cooperatively block exposed PS in combination with other procoagulants and thus together inhibit more PCA of target APL cells. Compared to phagocytosis without lactadherin, lactadherin-opsonized engulfment might block higher amounts of cell-surface annexin II and consequently decrease more FLA of APL targets. Therefore, lactadherin and phagocytes cooperation can be utilized for modulating coagulation in APL.
In conclusion, we demonstrate that phagocytosis of APL cells by MΦ and ECs in vitro results in prevention of APL coagulation disorder. Lactadherin-enhanced engulfment of APL cells may be used to decrease the amount of leukemic cells. The capacity of lactadherin and phagocytes to cooperatively decrease clot-promoting activity may be an attractive strategy for treatment of PS-related coagulopathy. Furthermore, lactadherin-mediated engulfment may be useful to improve the hyperfibrinolytic states in APL.
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